Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by KQED. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KQED or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

What RFK Jr.’s Support for Psychedelic Therapy Means for Its Future

54:48
 
Share
 

Manage episode 518034328 series 2489871
Content provided by KQED. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KQED or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This summer, Health and Human Services Secretary Robert F. Kennedy, Jr. said he’d like to see psychedelic therapies for depression, trauma and other hard-to-treat disorders approved for use within the next 12 months. Last year the FDA rejected psychedelic-assisted therapy for use in treating PTSD. We check in with long-time researchers about how state and federal governments can influence the momentum of their field, how they’re reconciling the new right wing support, and what it all means for the future of psychedelic research and therapy.

Guests:

Michael Silver, director, UC Berkeley Center for the Science of Psychedelics

Marlena Robbins, Indigenous public health and policy consultant; doctor of public health candidate, UC Berkeley

Berra Yazar-Klosinski, founder and CEO, Yazar Lab, LLC; former chief scientific officer, Lykos Therapeutics

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

3132 episodes

Artwork
iconShare
 
Manage episode 518034328 series 2489871
Content provided by KQED. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by KQED or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

This summer, Health and Human Services Secretary Robert F. Kennedy, Jr. said he’d like to see psychedelic therapies for depression, trauma and other hard-to-treat disorders approved for use within the next 12 months. Last year the FDA rejected psychedelic-assisted therapy for use in treating PTSD. We check in with long-time researchers about how state and federal governments can influence the momentum of their field, how they’re reconciling the new right wing support, and what it all means for the future of psychedelic research and therapy.

Guests:

Michael Silver, director, UC Berkeley Center for the Science of Psychedelics

Marlena Robbins, Indigenous public health and policy consultant; doctor of public health candidate, UC Berkeley

Berra Yazar-Klosinski, founder and CEO, Yazar Lab, LLC; former chief scientific officer, Lykos Therapeutics

Learn more about your ad choices. Visit megaphone.fm/adchoices

  continue reading

3132 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play